Dear Colleagues,

I am thrilled to share recent article titled, “Greater Understanding of Cell & Gene Therapies Supports Plan Coverage,” published in the November issue of the Self-Insurer. This article dives into the rising cost and challenges of cell & gene therapies (CGTs) for the self-insurance community and how employers can best prepare their health plans against these unpredictable healthcare costs. Read more in the article found in the Self-Insurer section of our website, where you can access my monthly articles written for the publication. 

You may remember Dr. Douglas Jones, Founder and CEO of Global Allergy Immune Network (GAIN) from a few issues ago here, discussing allergy and immune care. In this issue, we are back with Dr. Jones to continue our conversation on Long COVID – trends in patient populations, risk factors, prevention strategies and how GAIN helps patients across the U.S. gain access to care.

Please stay safe and tell me how you are breaking ground in these growing industries.

Laura Carabello
Executive Editor and Publisher
Medical Travel & Digital Health News
lcarabello@cpronline.com
https://twitter.com/MTT_eNews
https://www.facebook.com/MTT.eNews
https://www.linkedin.com/company/medical-travel-today